Wasatch Advisors Lp

13F Holdings History for C4 Therapeutics, Inc. - Common Stock (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 7.47M shares
Security Ownership: 10.5%

Shares, Excluding Options vs Price

Value, Excluding Options

WASATCH ADVISORS LP ownership in C4 Therapeutics, Inc. Common Stock (CCCC)

2025-05-07 - WASATCH ADVISORS LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.47M shares of C4 Therapeutics, Inc. Common Stock (CCCC). This represents 10.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
WASATCH ADVISORS LP	10.5%		$9.27M	7.47M			$1.24	13G/A	4/30/2025	7 May 2025 13:39:49

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.06%	+0.01%	$10.6M	7.42M	+700,253	+10.4%	$1.43	Q2 2025
3/31/2025	0.06%	+0.01%	$10.8M	6.72M	+651,808		$1.60	Q1 2025
12/31/2024	0.11%	+0.01%	$21.9M	6.07M	+395,233	+6.96%	$3.60	Q4 2024
9/30/2024	0.16%	+0.02%	$32.4M	5.68M	+830,218	+17.1%	$5.70	Q3 2024
6/30/2024	0.12%	+0.01%	$22.4M	4.85M	+518,671	+12%	$4.62	Q2 2024
3/31/2024	0.18%	-0.13%	$35.4M	4.33M	-2,810,470	-39.4%	$8.17	Q1 2024
12/31/2023	0.22%	+0.03%	$40.3M	7.14M	+891,808	+14.3%	$5.65	Q4 2023
9/30/2023	0.07%	-0.01%	$11.6M	6.25M	-952,350	-13.2%	$1.86	Q3 2023
6/30/2023	0.12%	+0.02%	$19.8M	7.2M	+1,483,470	+26%	$2.75	Q2 2023
3/31/2023	0.11%	0%	$17.9M	5.72M	-59,677	-1.03%	$3.14	Q1 2023
12/31/2022	0.23%	-0.01%	$34.1M	5.78M	-158,778	-2.68%	$5.90	Q4 2022
9/30/2022	0.36%	+0.02%	$52M	5.93M	+267,818	+4.73%	$8.77	Q3 2022
6/30/2022	0.27%	+0.2%	$42.7M	5.67M	+4,128,133	+268%	$7.54	Q2 2022
3/31/2022	0.18%	+0.03%	$37.3M	1.54M	+243,063	+18.8%	$24.26	Q1 2022
12/31/2021	0.17%	-0.01%	$41.7M	1.3M	-46,585	-3.47%	$32.20	Q4 2021
9/30/2021	0.24%	-0.01%	$60M	1.34M	-47,442	-3.41%	$44.68	Q3 2021
6/30/2021	0.21%	+0.05%	$52.6M	1.39M	+304,482	+28.1%	$37.84	Q2 2021
3/31/2021	0.18%	+0.2%	$40.1M	1.09M	+1,085,007	NEW	$36.99	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.